Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice
Baxter
UBS
Queensland Health
Fish and Richardson
Boehringer Ingelheim
Colorcon
Argus Health

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,948,751

« Back to Dashboard

Summary for Patent: 5,948,751
Title: X14-mannitol
Abstract:Insulin preparations of superior physical stability, comprising dissolved and/or precipitated human insulin or an analogue or derivative thereof, and a water-soluble reduced or non-reducing carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or a water-soluble non-reducing ester and/or ether derivative of a carbohydrate or reduced carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or mixtures thereof are disclosed.
Inventor(s): Kimer; Lone L.o slashed.gstrup (Farum, DK), Balschmidt; Per (Esperg.ae butted.rde, DK), Jensen; Steen (Drag.o slashed.r, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:08/879,691
Patent Claim Types:
see list of patent claims
Compound; Formulation; Process; Use;

Drugs Protected by US Patent 5,948,751

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,948,751

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark684/96Jun 20, 1996
Denmark899/96Aug 27, 1996

International Patents Family Members for US Patent 5,948,751

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine 72427 ➤ Try a Free Trial
Russian Federation 2204411 ➤ Try a Free Trial
Poland 188736 ➤ Try a Free Trial
Poland 330828 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Deloitte
Queensland Health
Accenture
McKesson
Argus Health
Healthtrust
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.